Chongqing Medical University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Chongqing China (1956)

Organization Overview

First Clinical Trial
2005
NCT00654576
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chengdu Women's and Children's Central Hospital | Chen Li | Children's Hospital of Chongqing Medical University | Children's Hospital of Chongqing Medical University, Chongqing, China | CHONGQING BANAN HOSPITAL OF TCM | Chongqing Cancer Hospital | Chongqing Emergency Medical Center | Chongqing First People's Hospital | Chongqing General Hospital | Chongqing Health Center for Women and Children | Chongqing Infectious Disease Medical Center | Chongqing Jiangbei Hospital of Traditional Chinese Medicine | Chongqing Liangping District People's Hospital | Chongqing Medical University | Chongqing Medical University No.1 Affiliated Hospital | Chongqing Mental Hospital | Chongqing Metal Institute | Chongqing Traditional Chinese Medicine Hospital | Chongqing University Cancer Hospital | Chongqing University Jiangjin Hospital | Chongqing University Three Gorges Hospital | Chongqing Yongchuan District People's Hospital | Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University | Dianjiang People's Hospital of Chongqing | First Affiliated Hospital of Chongqing medical university | First Affiliated Hospital of Chongqing Medical University | Fulin Central Hospital of Chongqing City | Fuling Central Hospital of Chongqing City | Fuling Hospital affiliated to Chongqing University | Genetic and Reproductive Institute, Chongqing Obstetrics and Gynecology Hospital | Jiulongpo People's Hospital of chongqing | People's Hospital of Changshou Chongqing | People's Hospital of Chongqing Hechuan | People's Hospital of Shapingba District， Chongqing | Qianjiang Central Hospital of Chongqing | Qifu Li | Shanxi Children's Hospital | Stomatological Hospital of Chongqing Medical University | The 2nd affiliated Hospital of Chongqing Medical University | The Affiliated Cancer Hospital of Chongqing University | The Fifth People Hospital of Chongqing | the First Affiliated Hospital, Chongqing Medical University, China | The First People's Hospital Of Chongqing Liang Jiang New Area | The People's Hospital of Chongqing Kaizhou District | The People's Hospital of DAZU ，Chongqing | The People's Hospital of Qijiang District，Chongqing | The People's Hospital of Tongliang District， Chongqing city | The People's Hospital of Yubei District of Chongqing city | The Second Affiliated Hospital, Chongqing Medical University | The Second Affiliated Hospital of Chongqing Medical University | The Second Affilicated Hospital of Chongqing Medical University | University-Town Hospital of Chongqing Medical University

Active Ingredients

Drugs in Phase 4 Trials (45)

amlodipine (norvasc) (1 trial)

aripiprazole (abilify) (2 trials)

caffeine (1 trial)

carrimycin (1 trial)

chloroquine (1 trial)

chlorpromazine (Thorazine) (1 trial)

clozapine (clozaril) (1 trial)

dexmedetomidine (precedex) (3 trials)

entecavir (baraclude) (1 trial)

esketamine (spravato) (4 trials)

ethambutol (myambutol) (1 trial)

exenatide (byetta) (1 trial)

fentanyl (Innovar) (1 trial)

fuganlin (1 trial)

haloperidol (haldol) (1 trial)

interferon alpha-2b (Intron-A) (3 trials)

isoniazid (nydrazid) (1 trial)

ketamine (ketalar) (1 trial)

levofloxacin (levaquin) (1 trial)

lopinavir (Kaletra) (1 trial)

midazolam (versed) (1 trial)

montelukast (singulair) (1 trial)

nifedipine (procardia) (2 trials)

olanzapine (zyprexa) (2 trials)

progesterone (progestasert) (1 trial)

propantheline bromide (pro-banthine) (1 trial)

propofol (diprivan) (2 trials)

pyrazinamide (Aldinamide) (1 trial)

quetiapine (seroquel) (1 trial)

ribavirin (virazole) (1 trial)

rifampin (1 trial)

risperidone (risperdal) (3 trials)

ritonavir (Norvir) (1 trial)

sitagliptin (januvia) (5 trials)

sodium chloride (4 trials)

somatropin (protropin) (3 trials)

sufentanil (1 trial)

sulpiride (1 trial)

tamsulosin (flomax) (2 trials)

tandospirone (1 trial)

telmisartan (micardis) (1 trial)

vitamin a (1 trial)

vitamin d3 (1 trial)

xiaoer jiebiao (1 trial)

xingnaojing (1 trial)

Drugs in Phase 3 Trials (26)

ambrisentan (letairis) (1 trial)

camrelizumab (4 trials)

capecitabine (xeloda) (4 trials)

carboplatin (paraplatin) (4 trials)

cetuximab (erbitux) (2 trials)

cisplatin (platinol) (9 trials)

docetaxel (taxotere) (4 trials)

enalapril (vasotec) (1 trial)

epirubicin (ellence) (1 trial)

esat6-cfp10 (1 trial)

fluorouracil (efudex) (3 trials)

folic acid (1 trial)

huachansu pian (1 trial)

icaritin (1 trial)

irinotecan (Camptosar) (2 trials)

leucovorin (2 trials)

nedaplatin (1 trial)

oxaliplatin (eloxatin) (2 trials)

paclitaxel (taxol) (6 trials)

platelet concentrate (1 trial)

rc48-adc (2 trials)

somatostatin (1 trial)

tamoxifen (nolvadex) (1 trial)

thrombopoietin (1 trial)

toremifene (fareston) (1 trial)

vinorelbine (navelbine) (1 trial)

Drugs in Phase 2 Trials (29)

ak112 (1 trial)

almonertinib (2 trials)

autologous umbilical cord blood (2 trials)

bcma-pd1-cart cell (2 trials)

bevacizumab (avastin) (2 trials)

brivanib alaninate (1 trial)

cc-223 (1 trial)

cd123 car-t cells (2 trials)

cd19 car-t cells (8 trials)

cd22 car-t cells (5 trials)

ciltacabtagene autoleucel (Carvykti) (1 trial)

conbercept (1 trial)

danazol (danocrine) (1 trial)

dexamethasone (2 trials)

durvalumab (imfinzi) (1 trial)

etoposide (vepesid) (1 trial)

filgrastim (neupogen) (1 trial)

fluzoparib (1 trial)

furmonertinib (1 trial)

gemcitabine (gemzar) (1 trial)

genakumab (1 trial)

iguratimod (1 trial)

lutropin alpha (luveris) (1 trial)

niraparib (zejula) (1 trial)

selinexor (Xpovio) (1 trial)

sintilimab (2 trials)

tacrolimus (prograf) (1 trial)

toripalimab (1 trial)

umbilical cord mesenchymal stem cells (4 trials)

Drugs in Phase 1 Trials (14)

anti-cd19 fast car-t cells (1 trial)

cd19 allo-car-t cells (1 trial)

cd7 car-t cell (1 trial)

ciprofol (1 trial)

cyclophosphamide (cytoxan) (3 trials)

doxorubicin (Doxil) (1 trial)

fludarabine (fludara) (2 trials)

Getagozumab (1 trial)

ibi188 (1 trial)

melphalan (alkeran) (2 trials)

mitoxantrone (novantrone) (1 trial)

pemetrexed (alimta) (1 trial)

recombinant new coronavirus vaccine (cho cells) (1 trial)

sargramostim (leukine) (1 trial)

Drugs in Other Trials (33)

albuterol (proventil) (3 trials)

autologous blood (2 trials)

azithromycin (zithromax) (1 trial)

betamethasone (celestone) (1 trial)

calcium (1 trial)

colchicine (colbenemid) (1 trial)

corticotropin (acthar) (1 trial)

cyproviron (1 trial)

dipyridamole (persantine) (1 trial)

enoxaparin (lovenox) (2 trials)

ethinyl estradiol (Estinyl) (1 trial)

follitropin beta (1 trial)

ganirelix (1 trial)

glimepiride (amaryl) (1 trial)

insulin glargine (toujeo) (2 trials)

insulin human (humulin) (1 trial)

iopamidol (Isovue) (1 trial)

lidocaine (xylocaine) (1 trial)

magnesium oxide (1 trial)

magnesium sulfate (Tis-U-Sol) (2 trials)

methylene blue (proveblue) (1 trial)

methylprednisolone (medrol) (2 trials)

mycophenolate (myfortic) (1 trial)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

rivaroxaban (xarelto) (1 trial)

ropivacaine (naropin) (1 trial)

sacubitril (Entresto) (1 trial)

sorafenib (nexavar) (1 trial)

surfactant (1 trial)

tolterodine (detrol) (1 trial)

triptorelin (Trelstar) (1 trial)

valsartan (diovan) (1 trial)

warfarin (coumadin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 4)

Atrial Fibrillation (Phase 4)

Breast Neoplasms (Phase 3)

Bronchopulmonary Dysplasia (Phase 2)

Calculi (Phase 4)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Cerebral Infarction (Phase 4)

Choroidal Neovascularization (Phase 2)

Cognitive Dysfunction (Phase 4)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 4)

Coronary Disease (Phase 3)

Coronavirus Infections (Phase 4)

Cough (Phase 4)

Delirium (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 1)

Depressive Disorder, Major (Phase 1)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Disease (Phase 1)

Dwarfism (Phase 3)

Dwarfism, Pituitary (Phase 2)

Esophageal Neoplasms (Phase 3)

Familial Primary Pulmonary Hypertension (Phase 1)

Fibrosis (Phase 2)

Gallbladder Neoplasms (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Herpangina (Phase 4)

Hyperplasia (Phase 2)

Hypertension (Phase 4)

Infections (Phase 4)

Infertility (Phase 2)

Ischemia (Phase 4)

Kidney Diseases (Phase 3)

Leukemia (Phase 2)

Leukemia, B-Cell (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, T-Cell (Phase 1)

Liver Cirrhosis (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Mental Disorders (Phase 4)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neovascularization, Pathologic (Phase 2)

Neutropenia (Phase 2)

Peritoneal Neoplasms (Phase 3)

Pituitary Diseases (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Psychomotor Agitation (Phase 4)

Psychotic Disorders (Phase 4)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Rectal Neoplasms (Phase 3)

Recurrence (Phase 4)

Renal Insufficiency, Chronic (Phase 3)

Respiratory Tract Infections (Phase 4)

Schizophrenia (Phase 4)

Stroke (Phase 4)

Thrombocytopenia (Phase 3)

Thyroid Diseases (Phase 4)

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 4)

Urinary Calculi (Phase 4)

Uterine Cervical Neoplasms (Phase 3)

Uveitis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 122
  • # of Trial APIs: 147